Dianthus Therapeutics (DNTH) Return on Sales (2023 - 2025)
Historic Return on Sales for Dianthus Therapeutics (DNTH) over the last 4 years, with Q3 2025 value amounting to 92.5%.
- Dianthus Therapeutics' Return on Sales fell 807800.0% to 92.5% in Q3 2025 from the same period last year, while for Sep 2025 it was 40.76%, marking a year-over-year decrease of 281900.0%. This contributed to the annual value of 13.55% for FY2024, which is 18100.0% up from last year.
- As of Q3 2025, Dianthus Therapeutics' Return on Sales stood at 92.5%, which was down 807800.0% from 163.34% recorded in Q2 2025.
- In the past 5 years, Dianthus Therapeutics' Return on Sales registered a high of 6.68% during Q3 2022, and its lowest value of 163.34% during Q2 2025.
- In the last 4 years, Dianthus Therapeutics' Return on Sales had a median value of 15.59% in 2024 and averaged 32.3%.
- As far as peak fluctuations go, Dianthus Therapeutics' Return on Sales surged by 42200bps in 2024, and later plummeted by -1539500bps in 2025.
- Over the past 4 years, Dianthus Therapeutics' Return on Sales (Quarter) stood at 8.56% in 2022, then crashed by -188bps to 24.68% in 2023, then increased by 15bps to 21.06% in 2024, then tumbled by -339bps to 92.5% in 2025.
- Its last three reported values are 92.5% in Q3 2025, 163.34% for Q2 2025, and 25.27% during Q1 2025.